Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,151 | -623,506 | -495,761 | -347,000 | -180,937 |
| Depreciation Amortization | 49,812 | 213,527 | 160,614 | 106,099 | 50,303 |
| Income taxes - deferred | 1,261 | -11,901 | -9,346 | -4,940 | -1,912 |
| Accounts receivable | -25,434 | 61,088 | 27,968 | 30,632 | 11,020 |
| Accounts payable and accrued liabilities | -4,817 | -52,180 | -89,268 | -79,339 | -66,048 |
| Other Working Capital | -56,843 | -26,377 | -94,734 | -75,050 | -76,003 |
| Other Operating Activity | 71,957 | 215,790 | 224,931 | 134,928 | 89,823 |
| Operating Cash Flow | $-38,215 | $-223,559 | $-275,596 | $-234,670 | $-173,754 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 112,743 | 321,586 | 275,002 | 190,200 | 80,363 |
| PPE Investments | -29,360 | -189,462 | -116,586 | -96,949 | -33,623 |
| Net Acquisitions | N/A | -14,686 | 685 | 685 | N/A |
| Purchase Of Investment | -442 | -42,823 | -26,827 | -26,667 | -1,172 |
| Other Investing Activity | 0 | -549 | -49 | -49 | -7 |
| Investing Cash Flow | $82,941 | $74,066 | $132,225 | $67,220 | $45,561 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 137,976 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 964 | 32,015 | 21,495 | 20,554 | 4,282 |
| Other Financing Activity | -5,344 | 44,470 | 44,887 | 45,593 | -1,547 |
| Financing Cash Flow | $133,596 | $76,485 | $66,382 | $66,147 | $2,735 |
| Exchange Rate Effect | 550 | 30 | -3,176 | -747 | -237 |
| Beginning Cash Position | 242,790 | 315,768 | 315,768 | 315,768 | 315,768 |
| End Cash Position | 421,662 | 242,790 | 235,603 | 213,718 | 190,073 |
| Net Cash Flow | $178,872 | $-72,978 | $-80,165 | $-102,050 | $-125,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,215 | -223,559 | -275,596 | -234,670 | -173,754 |
| Capital Expenditure | -29,360 | -214,462 | -141,586 | -96,949 | -33,623 |
| Free Cash Flow | -67,575 | -438,021 | -417,182 | -331,619 | -207,377 |